Skip to main content
. 2001 Jan 22;2001(1):CD002060. doi: 10.1002/14651858.CD002060

Romagnoli 1992.

Methods Blinding of randomisation: no 
 Blinding of intervention: can't tell but probably impossible 
 Complete follow‐up: yes 
 Blinding of outcome measurement: can't tell
Participants Term infants. 
 Infants with birth asphyxia, hypoglycaemia, gastrointerstinal pathology or haemolysis excluded. Infants of mothers with diabetes or who received corticosteroids or barbiturates excluded. 
 Qualifying SBR >205 up to 72 hours, >256 after 72 hours. 
 Fibreoptic n=23, no treatment n=23.
Interventions Fibreoptic: Wallaby at 8‐10 microwatts/cm2/nm (set).
Outcomes Absolute change in SBR at 12 and 24 hour. 
 % change in SBR at 12 and 24 hours. 
 Use of exchange transfusion. 
 Use of additional phototherapy.
Notes Data complete
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? High risk C ‐ Inadequate